Argonaut Technologies to Sell Stock, Certain Assets to Biotage AB

Argonaut Technologies has entered into a definitive agreement under which Argonaut Technologies will sell stock and certain assets of its consumables and flash chromatography business to Biotage AB of Uppsala, Sweden. The transaction is valued at approximately $20 million in cash, and once consummated will fulfill the first phase of the company's planned effort to maximize shareholder value through strategic transactions.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqHQ8ubWbmduZCdy5otu)